Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Don Westermeyer who wrote (1368)	1/23/1998 11:53:00 AM
From: Oeconomicus	Read Replies (1) \| Respond to of 164684

BTW, I meant to respond to John, but don't want to go back and find his last post. There have been so many. He asked what could make it go down since none of our theories have panned out so far. John, the answer is "nothing". You may be right, but consider that all the "good" news is out. The only thing left for the bulls is to wait and hope for more good news three months from now and also hope that no "bad" news comes out in the meantime. Now, everyone sits around wondering about the future and trying to figure out what the Q4 numbers really mean while employee and insiders could be thinking "now's the time". Possible "bad" news? Any insider selling. BKS' Web site moving up the rankings. Realization that the next Q won't be so good and that the last Q proves the "the more they sell, the more they lose" theory. Realization that AMZN is not a tech stock, that it is just a book seller and that booksellers typically only make money 1 Q a year if at all. You may well see your price John. Will you sell if it gets to $70? This stock sure plants the doubts in one's mind I'll grant. What are the stages? Shock - "74%?"; Anger - "Those SOBs will squeeze us dry"; Bargaining - "I swear I'll never trade options again if I can just get out of this without a total loss". What's next? Hey, maybe the market will find a miracle cure for this insanity. Call it Crashindex, subject to FDA approval. Regards, Bob